发明名称 |
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
摘要 |
This invention is directed to the (S)-enantiomer of the compound of formula (I):;
or a pharmaceutically acceptable solvate or prodrug thereof. This (S)-enantiomer is useful for the treatment of diseases or conditions, such as pain, which are ameliorated or alleviated by the modulation of voltage-gated sodium channels. |
申请公布号 |
US9480677(B2) |
申请公布日期 |
2016.11.01 |
申请号 |
US201414510634 |
申请日期 |
2014.10.09 |
申请人 |
Xenon Pharmaceuticals Inc. |
发明人 |
Chafeev Mikhail;Fu Jianmin;Cadieux Jean-Jacques Alexandre |
分类号 |
A61K31/407;C07D491/22;C07D491/20 |
主分类号 |
A61K31/407 |
代理机构 |
Seed IP Law Group LLP |
代理人 |
Seed IP Law Group LLP |
主权项 |
1. A method of treating familial erythromelalgia and primary erythromelalgia in a mammal by the inhibition of ion flux through a voltage-gated sodium channel in the mammal, wherein the method comprises administering to the mammal in need thereof a therapeutically effective amount of the (S)-enantiomer of 1′-{[5-(trifluoromethyl)furan-2-yl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3′-indol]-2′(1′H)-one having the following formula (I-S): or a pharmaceutically acceptable solvate or prodrug thereof. |
地址 |
Burnaby, BC CA |